Learn how to measure the true span and cost of menopause across your workforce, including the pre-diagnosis care that never shows up in claims data, and build the ROI case for a managed, full-lifecycle menopause benefit.
Countdown to Unbundling: What You Need to Know for 2027
Learn how upcoming CMS billing changes will restructure maternity care coding starting January 2027, so employers can get ahead of the impact on their 2027 renewal and benefits budget.
Why Oncofertility Support Gaps Are a Growing Employer Risk
Learn how leading employers are exposed to oncofertility risk — and what coordinated cancer and fertility support looks like when it's built to meet employees at the moment that matters most.
Maven Clinic and Wellthy are joining forces to bring together clinical care and caregiving support, helping employees better manage these demands while improving engagement and outcomes.
Maven Clinic Board Member Rachel Winokur, Maven CFO Katie Rooney, and MercerWell Senior Consultant Lindsay Bower come together to cut through the noise and help employers evaluate the market more clearly.
Color & Maven: Cancer, fertility, and the future of women's health
Hear how Maven and Color have built an integrated oncofertility care pathway that embeds fertility preservation directly into oncologist-led cancer care, as a coordinated, proactive model of care.
When Coverage Isn’t Enough: Closing Gaps in Access, Trust, and Cost
Unpack Maven's 5th annual State of Women's and Family Health Benefits report with us. Leaders from Pinterest and Alliant share what they're seeing across organizations today and how employers are adapting.
Implementación de la nueva política de FIV: su ventaja competitiva
Con una nueva Orden Ejecutiva de la Casa Blanca, los beneficios de fertilidad están cambiando más rápido que nunca. Únase a nosotros para descubrir cómo desarrollar una estrategia de beneficios de fertilidad y maternidad que genere impacto y eficiencia.
Olvídate del ruido de la menopausia y descubre mejores beneficios.
La menopausia es más visible que nunca, pero la mayoría de las empleadas aún carecen de apoyo: el 64% no sabe cómo controlar los síntomas y casi tres cuartas partes afirman que estos síntomas afectan a su trabajo, lo que aumenta los costes y la rotación de personal. Lea